Gerald Fornwald, Attorney, Winthrop & Weinstine, P.A.
Jennifer Lohse, General Counsel, Hazelden Betty Ford Foundation
- With the opioid crisis reaching unprecedented levels, integrated treatment is more important than ever. But 42 CFR part 2 limits the scope of information that treating providers can receive about a patient’s addiction history.
- How can treatment providers navigate tension between obligations such as their duty to warn, mandated reporting, and maintaining privacy obligations?
- Regulatory agencies and litigants are increasingly focusing on prescriber practices. What risks do prescribers face, and how can they reduce those risks if they may not have the patient’s whole medical history?
Presentation & handouts
DOWNLOAD MP4 FILE
To save the video to your computer right-click the link above then choose SAVE TARGET AS (or SAVE LINK AS) then save the file.